Biosig technologies announces intent to acquire the assets of neuro-kinesis corporation

Los angeles, july 31, 2024 (globe newswire) -- biosig technologies, inc. (otcqb: bsgm) (“biosig” or “company”), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization for electrophysiology (ep) procedures, today announced the intent to acquire the assets of neuro-kinesis corporation (nkc), a privately held los angeles-based medical technology company developing smart ep tools.
BSGM Ratings Summary
BSGM Quant Ranking